Clinical trial
Patient-centered, Optimal Integration of Survivorship and Palliative Care
NCT04900935
Study timeline
Study start (actual)2023-09-29Date precision: day
Registry last updated2025-11-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Stage IV Non-small Cell Lung Cancerunresolved
Targeted Therapyunresolved
Nonsmall Cell Lung Cancerunresolved
Carcinoma, Non-Small-Cell Lungunresolved
ALK-positive Non-small Cell Lung Cancerunresolved
EGFR Positive Non-small Cell Lung Cancerunresolved
Palliative Careunresolved
Survivorshipunresolved
Interventions
POISEBEHAVIORAL
Sponsors & collaborators
Massachusetts General Hospitallead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04900935 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.